Sort
64,565 grants matching “drug discovery”
RESCUE OF ALPORT SYNDROME OTOPATHOLOGY
$475,226Dominic E Cosgrove · Father Flanagan'S Boys' Home · R01 · FY2020 · DC
New Reagents for Synthesis of High Potency siRNA
$475,210Xianbin Yang · Am Biotechnologies, Llc · R44 · FY2011 · GM
Identification of novel secondary metabolites produced by symbiotic Proteobacte
$475,202Jon Clardy · University Of Wisconsin-Madison · U19 · FY2018 · AI
Identification of novel secondary metabolites produced by symbiotic Proteobacte
$475,202Jon Clardy · University Of Wisconsin-Madison · U19 · FY2016 · AI
Identification of novel secondary metabolites produced by symbiotic Proteobacte
$475,202Jon Clardy · University Of Wisconsin-Madison · U19 · FY2017 · AI
Interaction of histamine-releasing factor with immunoglobulins in asthma
$475,181Toshiaki Kawakami · La Jolla Institute For Immunology · R01 · FY2017 · HL
Mapping and Understanding Production of Natural Products in Fungi
$475,130Neil L Kelleher · Northwestern University · R01 · FY2025 · AT
Development of Wolter Capillary Condenser for High Throughput X-ray Microscopy
$475,107Wenbing Yun · Xradia, Inc. · R44 · FY2008 · RR
Metagenetic analysis of microbial community behavior
$475,105Jo E Handelsman · University Of Wisconsin-Madison · RC1 · FY2009 · DK
Metabolomics driven discovery of drug leads from symbiotic bacteria
$475,093David R Andes · University Of Wisconsin-Madison · U19 · FY2016 · AI
Experimental Therapeutics
$475,056Max S. Wicha · University Of Michigan At Ann Arbor · P30 · FY2015 · CA
Biochemical Mechanism of HIV DNA Integration
$475,037Alan N. Engelman · Dana-Farber Cancer Inst · R37 · FY2010 · AI
A Machine Learning Platform for Adaptive Chemical Screening
$475,021Anthony James Gitter · Morgridge Institute For Research, Inc. · R01 · FY2020 · GM
Development and validation of small molecules to treat neurofibromatosis associated schwannoma
$475,000Joseph Kissil · Scripps Florida · R21 · FY2019 · NS
Biocatalytic C -H Functionalization Logic in the Chemoenzymatic Synthesis of Therapeutic Natural Products
$475,000Hans Renata · Scripps Florida · R35 · FY2019 · GM
Biocatalytic C -H Functionalization Logic in the Chemoenzymatic Synthesis of Therapeutic Natural Products
$475,000Hans Renata · Scripps Florida · R35 · FY2020 · GM
Molecular mechanisms of chromatin and epigenetic regulation
$475,000Scott Rothbart · Van Andel Research Institute · R35 · FY2021 · GM
Biocatalytic C -H Functionalization Logic in the Chemoenzymatic Synthesis of Therapeutic Natural Products
$475,000Hans Renata · Scripps Florida · R35 · FY2018 · GM
Molecular mechanisms of chromatin and epigenetic regulation
$475,000Scott Rothbart · Van Andel Research Institute · R35 · FY2019 · GM
Trans-NIH RNAi Facility (TNRF)
$475,000Anton Simeonov · National Center For Advancing Translational Sciences · ZIC · FY2015 · TR
LRRK2 Enzymatic Mechanisms of Neurodegeneration in Parkinson's Disease
$475,000Darren John Moore · Van Andel Research Institute · R01 · FY2023 · NS
Molecular mechanisms of chromatin and epigenetic regulation
$475,000Scott Rothbart · Van Andel Research Institute · R35 · FY2017 · GM
Molecular mechanisms of chromatin and epigenetic regulation
$475,000Scott Rothbart · Van Andel Research Institute · R35 · FY2020 · GM
LRRK2 Enzymatic Mechanisms of Neurodegeneration in Parkinson's Disease
$475,000Darren John Moore · Van Andel Research Institute · R01 · FY2021 · NS
Pharmacological targeting of circadian clock components to treat glioblastoma
$475,000Satchidananda Panda · Salk Institute For Biological Studies · R01 · FY2021 · CA